-- First Solar, GameStop, Ladish, Merck, Rino: U.S. Equity Movers
-- B y   L u   W a n g
-- 2010-11-17T15:25:38Z
-- http://www.bloomberg.com/news/2010-11-16/bob-evans-comerica-cvr-energy-dynegy-human-genome-u-s-equity-preview.html
Shares of the following companies
are having unusual moves in U.S. trading. Stock symbols are in
parentheses and prices are as of 10:10 a.m. in New York.  Solar shares declined after Credit Suisse Group AG cut the
industry’s recommendation to “market weight” from
“overweight,” saying subsidy-driven demand can’t keep up with
surging supply.  First Solar Inc.  (FSLR US) fell the most in the
Standard & Poor’s 500 Index, losing 3.8 percent to $125.73.
 Renesola Ltd.  (SOL US) dropped 7.1 percent to $9.12.  Suntech
Power Holdings Co.  (STP US) slid 7 percent to $7.76.  JA Solar
Holdings Co.  (JASO US) dropped 8 percent to $7.22.  Trina Solar
Ltd.  (TSL US) retreated 5 percent to $22.51.  Bob Evans Farms Inc.  (BOBE US) gained 6.7 percent to $31.81
after advancing as much as 7.7 percent, the most intraday since
Dec. 4. The restaurant owner and sausage maker reported second-
quarter sales that missed some analyst estimates, according to a
Bloomberg survey.  Booz Allen Hamilton Holding Corp.  (BAH US) jumped 9.9
percent to $18.69 on the first day of trading. The government-
consulting firm acquired by Carlyle Group in 2008 raised $238
million in an initial public offering.       Chico’s FAS Inc.  (CHS US) rose 7.3 percent to $10.81 after
climbing 9.2 percent earlier, the most intraday since Sept. 14.
The women’s clothing retailer reported third quarter earnings of
16 cents, beating the average analyst estimate by 1 cent. Sales
were $483 million, higher than the $476.6 million projected by
analysts.  China Digital TV Holding Co.  (STV US) advanced 7.5 percent
to $7.32 and increased 9.4 percent earlier, the most intraday
since Oct. 14. The vendor of digital television software
forecast fourth-quarter sales of at least $20.8 million. That
beat the average analyst estimate of $16.1 million in a
Bloomberg survey.  Comerica Inc.  (CMA US) rose 2.1 percent to $37.51 and added
3.5 percent earlier, the most intraday since Nov. 5. The Dallas-
based bank that posted annual profits throughout the financial
crisis doubled its quarterly dividend to 10 cents and authorized
the repurchase of up to 7 percent of shares outstanding.  CVR Energy Inc.  (CVI US) fell 8.9 percent to $10.05 after
dropping as much as 11 percent, the most intraday since November
2009. The Sugar Land, Texas-based oil refiner said shareholders
including Goldman Sachs Group Inc. and Kelso & Co. will sell 15
million shares in a secondary public offering.       Duoyuan Global Water Inc.  (DGW US) jumped 6.1 percent to
$12.80 and climbed 11 percent earlier, the most intraday since
Sept. 28. The Chinese water-treatment equipment supplier posted
fourth quarter earnings of 55 cents a share, exceeding the 48-
cent average estimate by analysts.  GameStop Corp.  (GME US) rose the most in the Standard &
Poor’s 500 Index, climbing 5.3 percent to $21.95. The world’s
largest video-game retailer was boosted to “outperform” from
“neutral” at Credit Suisse Group AG, which cited the company’s
improving earnings outlook and “strong cash flow.”  Human Genome Sciences Inc.  (HGSI US) declined 4.9 percent
to $24.61. The Rockville, Maryland-based company was cut to a
“hold” from a “buy” by Citigroup Inc. analyst  Yaron Werber .  The stock rallied earlier after winning a U.S. advisory
panel’s backing together with  GlaxoSmithKline Plc  (GSK US) to
sell the first new lupus drug, Benlysta, in more than 50 years.
While the Food and Drug Administration isn’t required to follow
its outside recommendations, it usually does.  Ladish Co.  (LDSH US) had the biggest gain in the Russell
2000 Index, surging 56 percent to $45.74. The maker of products
for jet engines agreed to be bought by  Allegheny Technologies
Inc.  (ATI US) in a cash-and-stock transaction valued at $778
million. Allegheny slipped 1.9 percent to $49.  Merck & Co.  (MRK US) rose the most in the Dow Jones
Industrial Average, climbing 1.9 percent to $34.76. The
company’s experimental drug, anacetrapib, raised levels of good
cholesterol, slashed bad cholesterol and may have helped
patients avert heart complications, without the safety risks
that prompted Pfizer Inc. (PFE US) to abandon a similar product
four years ago, according to a study funded by Whitehouse
Station, New Jersey-based Merck.       Petroleum Development Corp.  (PETD US) fell 6.8 percent to
$34.03 and slipped to $33.96 earlier, the lowest intraday price
since Nov. 3. The oil and gas company said it will offer $100
million of convertible notes due 2016 and 3 million shares.
Proceeds will be used to fund an acquisition.  Rino International Corp.  (RINO US) slumped 15 percent to
$6.02 after tumbling to $5.68 earlier, the lowest intraday price
since May 2009. The provider of water treatment systems for
steelmakers postponed a conference call originally scheduled
yesterday to discuss third-quarter earnings, without giving a
reason. Faruqi & Faruqi LLP, a New York-based securities firm,
said it’s investigating the company on behalf of shareholders on
possible violations of the federal securities laws and breaches
of fiduciary duties by its officers.       Target Corp.  (TGT US) rose 3.1 percent to $55.21. The
second-largest U.S. discount retailer posted a profit, excluding
a tax gain, of 68 cents a share, matching the average analyst
estimate.  To contact the reporter on this story:
Lu Wang in New York at   lwang8@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at   nbaker7@bloomberg.net . 